The "golden bullet" against the flu?
Shionogi & Co has completed the first phase of testing the drug, in which it was tested for harmlessness. In November, when the peak of the flu epidemic is expected, the 2nd phase of clinical trials will begin - testing its effectiveness.
02.11.2015